AIM
STJ

Acropolis Investment Management’s St Jude Medical STJ Stock Holding History

Acropolis Investment Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5,436
Closed -$436K – 142
2016
Q4 		$436K Buy
5,436
+860
+19% +$68.3K 0.08% 92
2016
Q3 		$365K Hold
4,576
– – 0.07% 94
2016
Q2 		$357K Buy
4,576
+235
+5% +$16.8K 0.07% 97
2016
Q1 		$239K Buy
4,341
+200
+5% +$10.9K 0.05% 110
2015
Q4 		$256K Sell
4,141
-85
-2% -$5.36K 0.05% 108
2015
Q3 		$267K Buy
4,226
+410
+11% +$29.3K 0.06% 104
2015
Q2 		$279K Sell
3,816
-260
-6% -$18.8K 0.05% 100
2015
Q1 		$267K Buy
4,076
+535
+15% +$35.6K 0.05% 108
2014
Q4 		$230K Hold
3,541
– – 0.04% 107
2014
Q3 		$213K Sell
3,541
-70
-2% -$4.57K 0.04% 110
2014
Q2 		$250K Sell
3,611
-415
-10% -$26.9K 0.05% 103
2014
Q1 		$263K Sell
4,026
-105
-3% -$6.83K 0.05% 100
2013
Q4 		$256K Sell
4,131
-775
-16% -$44.9K 0.06% 99
2013
Q3 		$263K Sell
4,906
-375
-7% -$19.3K 0.06% 100
2013
Q2 		$241K Buy
+5,281
New +$229K 0.05% 94

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Acropolis Investment Management's STJ Position: Q1 2017 in Review

Acropolis Investment Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,436 shares — an estimated $436K sold.

Acropolis Investment Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $436K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Acropolis Investment Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Acropolis Investment Management sold 5,436 St Jude Medical shares in Q1 2017, an estimated $436K.
  • Acropolis Investment Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Acropolis Investment Management's St Jude Medical position peaked at $436K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Acropolis Investment Management's 13F filing for Q1 2017, filed 6 Apr 2017.